Zobrazeno 1 - 10
of 1 402
pro vyhledávání: '"chronic HCV"'
Autor:
Christian Medina, Alexis Hipólito García, Francis Isamarg Crespo, Félix Isidro Toro, Soriuska José Mayora, Juan Bautista De Sanctis
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 10, Pp 8255-8276 (2023)
Hepatitis C virus (HCV) infection is a worldwide public health problem. Chronic infection with HCV can lead to liver cirrhosis or cancer. Although some immune-competent individuals can clear the virus, others develop chronic HCV disease due to viral
Externí odkaz:
https://doaj.org/article/01b65642f38741e4a53b4238bc91ac71
Autor:
Jia Liu, Wenqian Qi, Song Wang, Yonggui Zhang, Xu Wang, Derong Sun, Yanhui Xu, Jingyi Shi, Honglei Duan, Qian Zhang, Hongguang Wang, Jiangbin Wang
Publikováno v:
Lipids in Health and Disease, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background Patients with chronic hepatitis C virus (HCV) infections differ in their risk for metabolic disorders and chronic kidney disease (CKD). The aim of this study was to investigate the effect of metabolic disorders induced by genetic
Externí odkaz:
https://doaj.org/article/25cbf2291a68460397eb300b138766d9
Autor:
Hany Samir Rasmy, Mohammed Abd Elfattah Elmalatawy, Khaled Zakaria ElKarmoty, Ebrahim Youssef Abdelwarth, Amira Isaac
Publikováno v:
Egyptian Liver Journal, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background Hepatitis C virus is the underlying cause of chronic hepatitis which frequently progresses to cirrhosis and hepatocellular carcinoma. In addition, HCV is thought to cause steatosis, dyslipidemia, insulin resistance, diabetes, obes
Externí odkaz:
https://doaj.org/article/4c5890c208d5400da1b9162571424818
Publikováno v:
Livers, Vol 3, Iss 1, Pp 82-92 (2023)
Globally, hepatocellular carcinoma (HCC) is a significant cause of mortality and morbidity among chronically infected HCV patients. It is established that HCV is a primary risk factor for HCC progression. The treatment of HCV infection has been trans
Externí odkaz:
https://doaj.org/article/f70ce0bf11dd4ba9a7e856cbcbe277e9
Publikováno v:
Сеченовский вестник, Vol 0, Iss 2, Pp 85-93 (2022)
Aim. Assessment of role of HBV viral proteins in liver disease progression in chronic HCV-infected patients.Methods. 2934 patients were included into the study, in whom serological markers of HBV- and HCV-infection were evaluated. 80 patients were ra
Externí odkaz:
https://doaj.org/article/af554853702d40aeaa0fd790c0dd7748
Publikováno v:
Frontiers in Virology, Vol 3 (2023)
IntroductionDespite advancements in hepatitis C virus (HCV) infection treatment, HCV still represents a significant public health burden. Besides progressive hepatic damage, viral persistence has lasting effects on innate and adaptive immune response
Externí odkaz:
https://doaj.org/article/5aa0de9bf9e54c96b3c7c306e63801b4
Autor:
Alshymaa A. Hassnine, Wail Soliman, Amr M. Elsayed, Mahmoud M. Higazi, Mery Saied, Ehab M. Abdelraheem
Publikováno v:
Egyptian Liver Journal, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Background Liver cirrhosis (LC) is the most common cause of portal hypertension. In chronic hepatitis C patients who are treated with direct-acting antiviral therapy (DAAS), the progression of cirrhosis can be reversed with treatment. Portal
Externí odkaz:
https://doaj.org/article/4b8ba0d3aa9743c1aa6f1aa7bd123d1f
Autor:
D. V. Garbuzenko
Publikováno v:
Вопросы вирусологии, Vol 66, Iss 5, Pp 331-339 (2021)
The formation of the liver cirrhosis (LC) is an unfavorable event of the natural history of chronic liver diseases being accompanied by complications that often cause a fatal outcome. The study of the effectiveness of drugs that affect various etiopa
Externí odkaz:
https://doaj.org/article/a35d010c9548416ea0d69bf192ce325c
Autor:
Nadia Abdel Ataay Abdelkader, Osama Ashraf Ahmed, Ahmed Fouad Sherief, Doaa Mahmoud Kandil, Mohammed Soliman Gado, Amira Mahmoud Al Balakosy
Publikováno v:
Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Background A large number of chronic hepatitis C patients had been successfully treated by directly acting antivirals; therefore, strategies for the long-term follow-up of these patients have to be planned based on the post-treatment fibrosi
Externí odkaz:
https://doaj.org/article/4601d669ac6d4444812d1551f5029c69
Publikováno v:
Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Background Hepatitis B virus (HBV) may reactivate when treating chronic hepatitis C (CHC) with direct-acting antivirals (DAA). We aimed to investigate the risk of HBV infection and reactivation during DAA therapy by performing a prospective
Externí odkaz:
https://doaj.org/article/bc78e18200014ba4ab727c4eddfba21f